申请人:UNIVERSITETET I OSLO
公开号:US10961223B2
公开(公告)日:2021-03-30
The invention provides compounds for use in a method of treating and/or preventing a bacterial infection in a human or non-human mammal, said method comprising administration of said compound in combination with (either simultaneously, separately, or sequentially) a β-lactam antibiotic, wherein said compound has the general formula I: (I) (wherein: Q is a lipophilic, zinc chelating moiety which is selective for Zn2+ ions and which comprises at least one, preferably two or more (e.g 2, 3 or 4), optionally substituted, unsaturated heterocyclic rings, e.g. 5 or 6-membered heterocyclic rings (such rings preferably include at least one heteroatom selected from N, S and O, preferably N); wherein any optional substituents may be selected from C1-6 alkyl, C1-6 alkoxy, halogen, nitro, cyano, amine, and substituted amine; each L, which may be the same or different, is a covalent bond or a linker; each W, which may be the same or different, is a non-peptidic hydrophilic group which comprises one or more hydroxy groups; and x is an integer from 1 to 3) or a stereoisomer, pharmaceutically acceptable salt or prodrug thereof.
本发明提供了用于治疗和/或预防人类或非人类哺乳动物细菌感染的方法的化合物,所述方法包括将所述化合物与β-内酰胺类抗生素(同时、分别或依次)联合给药,其中所述化合物具有通式I: (I) (其中:Q 是对 Zn2+ 离子有选择性的亲脂性锌螯合基团,它包括至少一个,最好是两个或更多 (例如 2、3 或 4 个)任选取代的不饱和杂环,例如5或6元杂环(此类环最好包括至少一个选自N、S和O的杂原子,最好是N);其中任选取代基可选自C1-6烷基、C1-6烷氧基、卤素、硝基、氰基、胺和取代胺;每个 L(可以相同或不同)是共价键或连接体;每个 W(可以相同或不同)是非肽亲水基团,包括一个或多个羟基;以及 x 是 1 至 3 的整数)或其立体异构体、药学上可接受的盐或原药。